BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6155101)

  • 1. Acute parotitis and hyperamylasemia following whole-brain radiation therapy.
    Cairncross JG; Salmon J; Kim JH; Posner JB
    Ann Neurol; 1980 Apr; 7(4):385-7. PubMed ID: 6155101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute transient parotitis after high dose etoposide and autologous bone marrow transplantation.
    Crump M; Brandwein JM; Scott JG; Sutcliffe SB; Keating A
    Bone Marrow Transplant; 1990 Oct; 6(4):259-61. PubMed ID: 1707701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of radioactive iodine therapy on parotid gland function.
    Maier H; Bihl H
    Acta Otolaryngol; 1987; 103(3-4):318-24. PubMed ID: 3495094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiotherapy of neurologic diseases].
    Lehmann W
    Psychiatr Neurol Med Psychol Beih; 1966; 4-5():83-95. PubMed ID: 5006316
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute radiation injuries of the brain developing during radiotherapy].
    Shishkina LV; Raevskaia SA
    Med Radiol (Mosk); 1989 Mar; 34(3):19-26. PubMed ID: 2927272
    [No Abstract]   [Full Text] [Related]  

  • 6. [Subacute brain atrophy induced by radiation therapy of malignant brain tumors].
    Asai A; Matsutani M; Takakura K
    Gan No Rinsho; 1987 Jun; 33(7):753-61. PubMed ID: 3613100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
    Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course and significance of acute hyperamylasemia in patients receiving fractionated therapeutic radiation to the parotid gland region.
    Borok TL; Cooper JS
    Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1449-51. PubMed ID: 6183243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic recurrent parotitis by roentgen irradiation under scintigraphic control].
    Glasenapp GB; Schmidt W; Kessler L; Otto HJ
    Z Laryngol Rhinol Otol; 1970 Aug; 49(8):520-5. PubMed ID: 5513126
    [No Abstract]   [Full Text] [Related]  

  • 10. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation effects on the parotid gland of mammals. Part 2: Modifications of plasma and parotid amylase activity.
    Balzi M; Cremonini D; Tomassi I; Becciolini A; Giannardi G; Pelù G
    Strahlentherapie; 1979 Aug; 155(8):566-9. PubMed ID: 473257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of gallium-67 citrate in salivary glands following radiation therapy.
    Lentle BC; Jackson FI; Mcgowan DG
    Am J Surg; 1976 Sep; 132(03):89-91. PubMed ID: 962004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory toxicity after parotid irradiation.
    Jones B
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):557. PubMed ID: 17433867
    [No Abstract]   [Full Text] [Related]  

  • 14. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy.
    Jen YM; Shih R; Lin YS; Su WF; Ku CH; Chang CS; Shueng PW; Hwang JM; Liu DW; Chao HL; Lin HY; Chang LP; Shum WY; Lin CS
    Radiother Oncol; 2005 May; 75(2):204-9. PubMed ID: 15908027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cause of hyperamylasemia associated with chronic liver disease.
    MacGregor IL; Zakim D
    Gastroenterology; 1977 Mar; 72(3):519-23. PubMed ID: 832801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum amylase in patients after radiotherapy as a probable bioindicator for radiation exposure.
    Hofmann R; Schreiber GA; Willich N; Westhaus R; Bögl KW
    Strahlenther Onkol; 1990 Oct; 166(10):688-95. PubMed ID: 1700482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy.
    Metz JM; Smith D; Mick R; Lustig R; Mitchell J; Cherakuri M; Glatstein E; Hahn SM
    Clin Cancer Res; 2004 Oct; 10(19):6411-7. PubMed ID: 15475427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed effects of therapeutic brain irradiation.
    Stewart-Amidei C
    Crit Care Nurs Clin North Am; 1995 Mar; 7(1):125-33. PubMed ID: 7766366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of postoperative radiation therapy of cerebral metastases on survival time and disease related to living condition].
    Winking M; Bräuer N; Lücke M; Nestler U; Böker DK
    Zentralbl Neurochir; 2002; 63(4):163-9. PubMed ID: 12518260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation.
    Rodrigues NA; Killion L; Hickey G; Silver B; Martin C; Stevenson MA; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1079-83. PubMed ID: 19327910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.